In Saccharomyces cerevisiae, RTC3 is a Hog1 kinase-dependent gene activated during osmotic stress. Studies utilize epitope-tagged RTC3 constructs (e.g., HA-tagged RTC3) for detection:
Antibody: Anti-HA antibody (3F10, Roche) is used to detect HA-tagged RTC3 via western blot .
Protocol:
RTC3 promoter activity is robustly induced by Hog1 kinase, even in the absence of stress .
Deletion of transcriptional activators (Hot1, Sko1) reduces RTC3 induction by only ~20–30%, suggesting partial dependence .
The promoter contains stress-response elements (STREs) regulated by the Ras/cAMP/Msn2/4 pathway .
While distinct from yeast RTC3, CRTC3 (CREB-regulated transcription coactivator 3) is a mammalian homolog studied in melanogenesis. Relevant antibodies include:
CRTC3 Antibody: Used in immunohistochemistry (1:100 dilution, Abcam) to localize CRTC3 in mouse and human tissues .
| Antibody | Application | Dilution | Source |
|---|---|---|---|
| Anti-CRTC3 | IHC, Western Blot | 1:100 | Abcam |
| Anti-HA (3F10) | Western Blot | 1:1,000 | Roche |
| Anti-Cdc2 (SC-54) | Loading Control | 1:1,000 | Santa Cruz |
CRTC3-null mice exhibit reduced melanin deposition due to downregulated MITF expression .
CRTC3 phosphorylation regulates its nuclear localization, impacting melanogenic gene transcription .
Altiratinib, a small-molecule inhibitor, suppresses CRTC3/CREB activity and melanogenesis in human melanocytes .
Cross-Reactivity: Anti-HA antibodies are specific to epitope tags and not endogenous RTC3. CRTC3 antibodies show reactivity in mouse and human tissues .
Validation: Western blotting with α-tubulin or HSP90 as loading controls ensures quantitative accuracy .
KEGG: sce:YHR087W
STRING: 4932.YHR087W
RTC3 (Regulator of Transcription C3) is a gene whose expression is significantly regulated by stress response pathways, particularly the Hog1 MAPK pathway in yeast models. RTC3 antibodies are crucial research tools for studying stress response mechanisms, as they allow researchers to detect and quantify RTC3 protein expression under various experimental conditions. The RTC3 protein has been identified as an important downstream effector in osmotic stress response pathways, making it valuable for understanding cellular adaptation mechanisms . Antibodies against RTC3 enable researchers to track expression patterns, subcellular localization, and potential post-translational modifications that may occur during stress responses.
RTC3 antibodies can be utilized in multiple detection methodologies similar to those employed for related proteins such as CRTC3. These methods include:
Immunohistochemistry (IHC): For tissue section analysis with appropriate antigen retrieval methods using pressure cooking (120.5°C for 30s followed by 90°C for 10s)
Western blotting: For detecting RTC3 protein levels in cell lysates and tissue homogenates
Immunofluorescence: Using secondary antibodies such as FITC-conjugated anti-mouse (1:500) or similar fluorophore-conjugated antibodies
Flow cytometry: For quantitative analysis of RTC3 expression in cell populations
Immunoprecipitation: For studying protein-protein interactions
When validating detection methods, researchers should include appropriate positive and negative controls, including RTC3 knockout samples generated through CRISPR/Cas9 gene editing techniques .
Proper validation of RTC3 antibodies is essential for reliable experimental results. A comprehensive validation approach should include:
Knockout validation: Generate RTC3 knockout cell lines using CRISPR/Cas9 technology. This requires:
Validation methods:
Flow cytometry analysis of antibody binding in wild-type versus knockout cells
Western blot analysis to confirm specific binding at the expected molecular weight
Sanger sequencing of the targeted genome region to confirm knockout
Immunofluorescence comparing staining patterns in control versus knockout samples
Cross-reactivity testing: Evaluate potential cross-reactivity with structurally similar proteins to ensure specificity.
For effective immunohistochemical detection of RTC3, researchers should follow this optimized protocol based on successful approaches with related proteins:
Tissue preparation:
Fix tissues in 4% paraformaldehyde
Process and embed in paraffin or optimal cutting temperature (OCT) compound for frozen sections
Cut sections at 5-7 μm thickness
Antigen retrieval:
Antibody incubation:
Visualization:
RTC3 antibodies are valuable tools for investigating stress-induced transcriptional responses, particularly in osmotic stress pathways. A comprehensive experimental approach includes:
Stress induction protocol:
Protein analysis workflow:
Extract total protein using appropriate lysis buffer
Quantify protein concentration using Bradford or BCA assay
Perform Western blot analysis using RTC3 antibody (1:1000 dilution)
Use phospho-specific antibodies to simultaneously monitor activation of upstream regulators (e.g., phospho-Hog1)
Correlation with transcriptional activity:
This integrated approach allows researchers to determine whether RTC3 protein levels correlate with transcriptional activation and understand the kinetics of the stress response.
Proper controls are essential for reliable immunoblotting with RTC3 antibodies:
Additionally, researchers should consider including samples from cells treated with factors known to activate RTC3 expression, such as osmotic stress conditions (0.7 M NaCl), to demonstrate dynamic range of detection .
For investigating interactions between RTC3 and transcription factors, researchers can employ these advanced methodological approaches:
Chromatin Immunoprecipitation (ChIP) analysis:
Co-immunoprecipitation (Co-IP) studies:
Prepare cell lysates under non-denaturing conditions
Immunoprecipitate with RTC3 antibody
Immunoblot for potential interacting transcription factors
Perform reciprocal Co-IP with antibodies against suspected interacting partners
Proximity ligation assay (PLA):
Fix cells and permeabilize
Incubate with primary antibodies against RTC3 and transcription factor of interest
Use species-specific PLA probes
Perform ligation and amplification steps
Analyze interaction signals by fluorescence microscopy
These techniques can help determine whether RTC3 directly interacts with transcription factors like Hot1 and Sko1, which have been implicated in the regulation of RTC3 expression , potentially revealing dual roles for RTC3 in both being regulated by and regulating transcriptional activity.
Post-translational modifications (PTMs) of RTC3 can significantly impact its function and localization. To study these modifications:
Phosphorylation analysis:
Generate or obtain phospho-specific RTC3 antibodies targeting predicted phosphorylation sites
Treat cells with phosphatase inhibitors during protein extraction
Compare Western blot results using total RTC3 antibody versus phospho-specific antibodies
Validate with lambda phosphatase treatment to confirm phosphorylation-specific signals
Mass spectrometry validation:
Immunoprecipitate RTC3 using validated antibodies
Perform liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Map identified modifications to the RTC3 protein sequence
Quantify modification stoichiometry under different conditions
PTM-specific antibody generation methodology:
Synthesize peptides containing the modified residue of interest
Conjugate to carrier protein (typically KLH)
Immunize rabbits or mice following standard protocols
Screen antisera for specificity against modified versus unmodified peptides
Affinity-purify antibodies using the immunizing peptide
This multi-faceted approach allows researchers to comprehensively characterize how stress conditions affect RTC3 post-translational modifications and subsequent function.
Combining RTC3 antibodies with CRISPR screen technology offers powerful insights into stress response pathway regulation:
CRISPR screen setup:
Generate a genome-wide CRISPR knockout library in cells of interest
Subject cells to osmotic or other stress conditions known to induce RTC3 expression
Select cells with abnormal RTC3 expression (high or low) using fluorescence-activated cell sorting (FACS) with labeled RTC3 antibodies
Sequence guide RNAs in selected populations to identify genes affecting RTC3 expression
Validation of screen hits:
Generate individual knockout cell lines for top candidate genes
Assess RTC3 protein levels by Western blot using RTC3 antibodies
Measure RTC3 promoter activity using reporter constructs like RTC3-LacZ
Perform RT-qPCR to quantify RTC3 mRNA levels
Analyze pathway components upstream and downstream of validated hits
Integration with functional assays:
Assess cellular phenotypes (survival, growth, morphology) in response to stress
Correlate phenotypes with RTC3 expression levels detected by antibody
Perform rescue experiments by reintroducing wild-type or mutant forms of identified genes
This approach, similar to the CRISPR screens described for CD3-bispecific antibody resistance mechanisms , can reveal novel regulators of RTC3 expression and function in stress response pathways.
Researchers frequently encounter specificity issues when working with RTC3 antibodies. Here are systematic approaches to address these challenges:
Cross-reactivity with related proteins:
Problem: RTC3 antibodies may cross-react with structurally similar proteins
Solution: Pre-adsorb antibody with recombinant related proteins
Validation: Compare staining patterns in tissues known to express only RTC3 versus tissues expressing related proteins
Non-specific binding:
Epitope masking:
Problem: Post-translational modifications or protein interactions may obscure antibody epitopes
Solution: Test multiple antibodies targeting different RTC3 epitopes
Validation: Compare results across different experimental conditions that may affect modifications
Validation protocol for questionable antibodies:
Optimizing immunofluorescence protocols for RTC3 detection requires systematic adjustment based on cell type:
Fixation optimization table:
| Cell/Tissue Type | Recommended Fixative | Duration | Temperature |
|---|---|---|---|
| Adherent cells | 4% Paraformaldehyde | 15 min | Room temperature |
| Suspension cells | 2% Paraformaldehyde | 10 min | Room temperature |
| Tissue sections | 4% Paraformaldehyde | 24 hours | 4°C |
| Yeast cells | 3.7% Formaldehyde | 30 min | Room temperature |
Permeabilization optimization:
Mild detergents (0.1% Triton X-100) for most mammalian cells
Stronger permeabilization (0.5% Triton X-100) for yeast cells with cell walls
Methanol permeabilization (-20°C, 10 min) for detecting some conformational epitopes
Antibody concentration titration:
Signal amplification strategies:
For low abundance proteins: Tyramide signal amplification
For co-localization studies: Use of higher quantum yield fluorophores
For quantitative analysis: Standardize exposure settings across all samples
Confocal microscopy settings:
Use appropriate laser power to minimize photobleaching
Optimize pinhole settings for best signal-to-noise ratio
Collect Z-stacks to ensure capturing the full subcellular distribution
Accurate quantification of RTC3 expression using antibody-based methods requires careful methodological considerations:
Western blot quantification:
Use gradient gels for optimal protein separation
Transfer proteins to low-fluorescence PVDF membranes for fluorescent detection
Employ fluorescent secondary antibodies for wider dynamic range than chemiluminescence
Include a standard curve of purified RTC3 protein for absolute quantification
Normalize to multiple housekeeping proteins to account for loading variations
Flow cytometry quantification:
Use calibrated fluorescent beads to standardize fluorescence intensity
Include appropriate isotype controls
Perform intracellular staining after fixing and permeabilizing cells
Gate populations based on viability and cell cycle phase
Calculate molecules of equivalent soluble fluorochrome (MESF) for standardized reporting
Image-based quantification protocol:
Acquire images using identical microscope settings across all samples
Perform background subtraction using no-primary-antibody controls
Define regions of interest (ROI) based on cell boundaries or subcellular compartments
Measure integrated density within ROIs
Normalize to cell area or DNA content
ELISA development for RTC3 quantification:
Generate a sandwich ELISA using two antibodies recognizing different RTC3 epitopes
Create standard curves using recombinant RTC3 protein
Validate assay linearity, sensitivity, and specificity
Determine appropriate sample dilutions to ensure measurements within the linear range
Investigation of RTC3's role in transcriptional regulatory networks during stress responses reveals complex coordination mechanisms:
RTC3 antibodies are valuable tools for investigating dynamic changes in RTC3 localization during stress responses:
Subcellular fractionation protocol:
Prepare cytoplasmic, membrane, nuclear, and chromatin-bound fractions using differential centrifugation
Perform Western blotting with RTC3 antibodies on each fraction
Include marker proteins for each compartment (e.g., GAPDH for cytoplasm, Histone H3 for chromatin)
Quantify relative distribution across fractions before and after stress induction
Live-cell imaging approaches:
Generate cells expressing fluorescently-tagged RTC3 (e.g., RTC3-GFP)
Validate that the tagged protein localizes similarly to endogenous RTC3 using RTC3 antibodies
Perform time-lapse microscopy during stress induction
Quantify nuclear/cytoplasmic ratios over time
Co-localization analysis:
Perform dual immunofluorescence with RTC3 antibodies and markers for:
Stress granules (G3BP1)
Processing bodies (DCP1)
Transcription factories (RNA Pol II)
Calculate Pearson's correlation coefficients for co-localization
Compare results across different stress conditions and timepoints
Trafficking mechanism investigation:
Treat cells with inhibitors of different trafficking pathways
Assess impact on RTC3 localization using antibody detection
Identify potential post-translational modifications that might regulate trafficking
Correlate trafficking patterns with functional outcomes (e.g., transcriptional activity)
These approaches can reveal how RTC3 localization changes during stress responses and how these changes correlate with its function in transcriptional regulation.
Multiplexed imaging with RTC3 antibodies requires careful optimization:
Antibody panel design considerations:
Select antibodies from different host species to minimize cross-reactivity
Choose fluorophores with minimal spectral overlap
Consider sequential staining for potentially competing antibodies
Include single-stain controls for spectral unmixing
Multiplexed immunofluorescence protocols:
Sequential staining approach:
Stain with first primary antibody (e.g., RTC3)
Detect with fluorophore-conjugated secondary
Block remaining secondary binding sites
Repeat with additional antibodies
Tyramide signal amplification (TSA) approach:
Use HRP-conjugated secondaries sequentially
Develop each with different fluorophore-tyramide conjugates
Inactivate HRP between cycles with hydrogen peroxide
Advanced multiplexing technologies compatibility:
Imaging mass cytometry:
Conjugate RTC3 antibodies with rare earth metals
Validate specificity after conjugation
Optimize concentration for signal-to-noise ratio
Cyclic immunofluorescence (CycIF):
Test RTC3 antibody compatibility with fluorophore quenching/elution
Confirm epitope stability through multiple cycles
Develop registration protocols for aligned images
Analysis considerations:
Apply machine learning algorithms for cell segmentation
Develop quantitative metrics for co-expression patterns
Account for autofluorescence through computational removal
Create visualization approaches for multi-dimensional data
These methodological considerations enable researchers to effectively incorporate RTC3 antibodies into complex multiplexed imaging experiments to understand RTC3's relationships with other proteins in stress response pathways.